Chevallard Daniel R.
Insider CIK 1706176 · VIRX CFO and COO · RGLS Chief Financial Officer · LENZ Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LENZ LENZ Therapeutics, Inc. | P Buy | 2026-03-27 | 2026-03-30 | 7,500 | $8.57 | $64.3K | 12,886 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 84,200 | — | $0 | 84,200 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-06 | 14,000 | — | $0 | 14,000 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | P Buy | 2025-11-07 | 2025-11-07 | 20 | $22.71 | $454 | 3,208 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | P Buy | 2025-11-07 | 2025-11-07 | 2,178 | $22.76 | $49.6K | 5,386 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2025-01-09 | 2025-01-13 | 70,444 | — | $0 | 70,444 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | P Buy | 2024-05-14 | 2024-05-15 | 3,188 | $15.68 | $50.0K | 3,188 | SEC↗ |
| LENZ LENZ Therapeutics, Inc. | A Award deriv | 2024-03-21 | 2024-03-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2024-03-12 | 2024-03-13 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2024-02-27 | 2024-02-27 | 3,405 | $0.73 | $2.5K | 102,306 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-02-25 | 2024-02-27 | 6,889 | — | $0 | 34,444 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-02-25 | 2024-02-27 | 6,889 | — | $0 | 105,711 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2023-11-28 | 2023-11-28 | 3,720 | $0.50 | $1.9K | 98,822 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-11-25 | 2023-11-28 | 6,889 | — | $0 | 41,333 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-11-25 | 2023-11-28 | 6,889 | — | $0 | 102,542 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2023-08-28 | 2023-08-29 | 3,512 | $1.45 | $5.1K | 95,653 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-08-25 | 2023-08-29 | 6,888 | — | $0 | 48,222 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-08-25 | 2023-08-29 | 6,888 | — | $0 | 99,165 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-05-25 | 2023-05-26 | 6,889 | — | $0 | 55,110 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2023-05-25 | 2023-05-26 | 3,635 | $1.42 | $5.2K | 92,277 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-05-25 | 2023-05-26 | 6,889 | — | $0 | 95,912 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2023-03-16 | 2023-03-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2023-02-27 | 2023-02-28 | 3,599 | $1.68 | $6.0K | 89,023 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-02-25 | 2023-02-28 | 6,889 | — | $0 | 61,999 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-02-25 | 2023-02-28 | 6,889 | — | $0 | 92,622 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2022-11-28 | 2022-11-29 | 3,532 | $2.72 | $9.6K | 85,733 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-11-25 | 2022-11-29 | 6,889 | — | $0 | 68,888 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-11-25 | 2022-11-29 | 6,889 | — | $0 | 89,265 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2022-08-26 | 2022-08-29 | 3,655 | $4.02 | $14.7K | 82,376 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-08-25 | 2022-08-29 | 6,889 | — | $0 | 75,777 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-08-25 | 2022-08-29 | 6,889 | — | $0 | 86,031 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2022-05-26 | 2022-05-27 | 3,596 | $1.90 | $6.8K | 79,142 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 6,889 | — | $0 | 82,666 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 6,889 | — | $0 | 82,738 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2022-03-17 | 2022-03-18 | 195,000 | — | $0 | 195,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2022-02-28 | 2022-03-01 | 3,998 | $2.78 | $11.1K | 75,849 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-02-25 | 2022-03-01 | 6,889 | — | $0 | 89,555 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-02-25 | 2022-03-01 | 6,889 | — | $0 | 79,847 | SEC↗ |
| VIRX | S Sale | 2021-11-29 | 2021-11-29 | 4,325 | $4.82 | $20.8K | 72,958 | SEC↗ |
| VIRX | S Sale | 2021-11-26 | 2021-11-29 | 3,254 | $4.80 | $15.6K | 77,283 | SEC↗ |
| VIRX | M Exercise deriv | 2021-11-25 | 2021-11-29 | 13,777 | — | $0 | 96,444 | SEC↗ |
| VIRX | M Exercise | 2021-11-25 | 2021-11-29 | 13,777 | — | $0 | 80,537 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2021-09-28 | 2021-09-29 | 10,000 | — | $0 | 88,817 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2021-09-28 | 2021-09-29 | 10,000 | $0.90 | $9.0K | 66,760 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2021-05-28 | 2021-06-01 | 12,000 | — | $0 | 98,817 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2021-05-28 | 2021-06-01 | 12,000 | $0.90 | $10.8K | 56,760 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2021-03-26 | 2021-03-30 | 78,912 | — | $0 | 78,912 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-07-01 | 2019-07-02 | 2,669 | $1.31 | $3.5K | 77,870 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-05-15 | 2019-05-16 | 10,000 | $1.41 | $14.1K | 80,539 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-05-14 | 2019-05-16 | 8,000 | — | $0 | 7,500 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-05-14 | 2019-05-16 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2019-05-14 | 2019-05-16 | 55,414 | — | $0 | 90,539 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | S Sale | 2019-04-01 | 2019-04-03 | 3,253 | $0.98 | $3.2K | 9,372 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2019-02-05 | 2019-02-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award | 2019-02-05 | 2019-02-06 | 30,000 | $0.95 | $28.5K | 34,578 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-05-17 | 2018-05-21 | 250,000 | — | $0 | 250,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2018-01-05 | 2018-01-05 | 350,000 | — | $0 | 350,000 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2017-07-25 | 2017-07-25 | 54,945 | $0.91 | $50.0K | 59,415 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | A Award deriv | 2017-05-10 | 2017-05-12 | 100,000 | — | $0 | 100,000 | SEC↗ |